Bioceres Crop Solutions (NASDAQ:BIOX) Price Target Lowered to $12.00 at Oppenheimer

Bioceres Crop Solutions (NASDAQ:BIOX) had its price target cut by Oppenheimer from $13.00 to $12.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s price target indicates a potential upside of 74.29% from the stock’s previous close.

Separately, Canaccord Genuity Group reduced their price objective on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a report on Wednesday, November 13th. Four equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Buy” and an average target price of $11.88.

Bioceres Crop Solutions Stock Down 1.5 %

Bioceres Crop Solutions stock opened at $6.89 on Tuesday. The company has a 50-day simple moving average of $6.65 and a 200-day simple moving average of $8.07. The firm has a market capitalization of $431.76 million, a P/E ratio of 348.42 and a beta of 0.56. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.87 and a current ratio of 1.27. Bioceres Crop Solutions has a one year low of $5.71 and a one year high of $14.05.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings data on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.11). The company had revenue of $92.60 million during the quarter, compared to analyst estimates of $117.15 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. During the same period in the previous year, the company earned ($0.07) EPS. As a group, equities analysts expect that Bioceres Crop Solutions will post 0.12 earnings per share for the current year.

Hedge Funds Weigh In On Bioceres Crop Solutions

Several hedge funds have recently made changes to their positions in BIOX. Stifel Financial Corp raised its stake in Bioceres Crop Solutions by 33.4% during the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock valued at $321,000 after purchasing an additional 10,224 shares during the period. Ping Capital Management Inc. grew its holdings in shares of Bioceres Crop Solutions by 7.3% during the fourth quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock valued at $268,000 after buying an additional 3,000 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Bioceres Crop Solutions by 9.5% during the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after buying an additional 5,341 shares during the period. JPMorgan Chase & Co. lifted its stake in Bioceres Crop Solutions by 49.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock worth $708,000 after acquiring an additional 29,693 shares in the last quarter. Finally, Fourth Sail Capital LP lifted its stake in Bioceres Crop Solutions by 61.6% in the 3rd quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company’s stock worth $24,957,000 after acquiring an additional 1,209,277 shares in the last quarter. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.